Industry News
Medical Device Industry News

Edwards Felt a 'Profound' Impact from Omicron
The company's U.S. business was hit harder from the variant's impact than other geographies, however.
Types of Urinary Incontinence and When to See a Doctor
Considering your age, you might think that you don’t have to worry about urinary incontinence. While it’s true that it usually affects the elderly, it can happen to anyone. This article provides several types of
PrinterPrezz & Uniformity Labs Team Up on Medical Device Manufacturing & More Supplier News
Here’s what was new in the world of medical device suppliers during the week of January 23.
Transcript of Let's Talk Medtech with John Babitt
John Babitt is Life Science partner at EY. He joins Let's Talk Medtech to discuss the state of M&A in 2022.
Will 2022 Be Medtech's Biggest Year for M&A?
Will 2022 be the year of medtech M&A. EY’s John Babitt joins us to talk about acquisition trends and deal-making activity in the latest episode of Let’s Talk Medtech.
WellSky® to Deliver In-Home Protocols for Patients With Heart Failure
Dr. Brent Lampert and Dr. Raymond Benza will lead the program at Ohio State Wexner Medical Center. The post WellSky® to Deliver In-Home Protocols for Patients With Heart Failure appeared first on Medical Device News
TearCare System for Meibomian Gland Dysfunction: Interview with Reay H. Brown, CMO of Sight Sciences
Sight Sciences, a medtech company based in California, specializes in devices to treat glaucoma and dry eye disease. The company has recently announced FDA 510(k) clearance for the TearCare System, a device designed to treat
Anti-COVID Nanobubbles Act as Viral Decoys
Researchers at Northwestern University have discovered naturally-occurring extracellular vesicles in the blood that contain the ACE2 protein, which is the cellular target of SARS-CoV-2. The vesicles act as a binding site for viral particles within
Enable Injections Announces $215 Million in Series C Financing
The funding from Magnetar will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling development and commercialization efforts. The post Enable Injections Announces $215 Million in Series C Financing appeared first on Medical Device News
NaoX Technologies Raises €4.3 Million
NaoX was co-founded in 2018 by Hugo Dinh, a graduate from Ecole Polytechnique, and Michel Le Van Quyen, a research director at Inserm, respectively CEO and Chief Scientific Officer. The post NaoX Technologies Raises €4.3
Medline Unveils New CLABSI Prevention Solution
The need for standardization in the vascular access health space is significant, especially with CLABSI incidents rapidly increasing since the onset of the pandemic. According to the Centers of Disease Control and Prevention (CDC), CLABSIs
Genetic and Lifestyle Calculator Reveals Which Younger Adults Are Most at Risk of Colorectal Cancer
Led by researchers at NYU Langone Health and its Laura and Isaac Perlmutter Cancer Center, the new study showed that those with the highest, or top third, combined polygenetic and environmental risk scores were four
FX Solutions, SAS. [FX Shoulder, Inc.] Completes Easytech Reversed® Stemless IDE Enrollment in the USA
"This is not only a major milestone for FX, but for the next generation of stemless shoulder arthroplasty and the way we think about reverse total shoulder arthroplasty. As a small company, we are excited
The Burden of Venous Leg Ulcers and Limited Health Literacy
Successful medical recovery often relies on a patient’s ability to independently manage and actively improve their own health condition. Being able to do this effectively requires an adequate level of health literacy (HL) – the
Common Causes Of Brain Injuries That You Need To Be Aware Of
Did you know that brain injury is one of the leading causes of death and disability in the United States? Each year, more than 2.5 million people sustain a traumatic brain injury, and 50,000 die
Occupational Hearing Loss In The Workplace: All You Need To Know
While none of us go to work expecting to be injured—the fact is that just as many of those employees who were exposed to hazardous substances like asbestos at work are now dealing with dreadful
Testing Is Key to Turning an Innovative Idea into a Successful Commercial Medical Device
Are you performing these 4 tests during medical device development?
NEJM: New Data on COVID-19 Lung Transplants
The analysis of more than 3,000 lung transplants in the U.S. between Aug. 1, 2020, and Sept. 30, 2021, showed that during the pandemic, 7% of the nation’s lung transplants were performed to treat severe,
Is Abbott Looking for M&A Opportunities?
CEO Robert Ford hinted at the types of acquisitions Abbott is most likely to go after in 2022.
University of Colorado School of Medicine Will Work with DreaMed Diabetes to Deploy Its Advisor System as a New Resource for Diabetes Device Initiation
“We are truly honored to be part of this project,” said Ryan Hovey, general manager for North America at DreaMed. “We have been able to demonstrate the ability to support endocrinology practices by centralizing patient



